CIBA Ltd. Selects Documentum to Accelerate Time-to-Market

CIBA Ltd., a multinational pharmaceutical company, has selected the Documentum Enterprise Document Management System (EDMS) as its corporate document management standard. This strategic move aims to accelerate and improve business processes, particularly in research, development, new drug submissions, production, sales, and marketing. The Documentum EDMS will enable CIBA's employees to transparently and consistently exchange documents across countries, ultimately reducing the time-to-market for new drugs.

Key Takeaways:

• CIBA Ltd. has chosen Documentum as its corporate document management standard to accelerate business processes and improve collaboration across the company.
• The Documentum EDMS will manage over 100,000-page new drug submissions, automating and accelerating the entire new drug submission cycle and drug development process.
• The system will store multiple document types, including scanned images, SAS tables, word processing files, graphics files, and tables of clinical trial data.
• CIBA will use the Documentum EDMS to ensure documentation and business processes involved in producing new drug submissions for multiple countries, each with its own specific criteria.
• The implementation will enable CIBA to capture and make available its intellectual capital, accumulated from past corporate experience.

Statistics:

• The Documentum EDMS will manage over 100,000-page new drug submissions.
• The system will handle multiple document types, including scanned images, SAS tables, word processing files, graphics files, and tables of clinical trial data.
• CIBA will implement the Documentum EDMS in its Pharma Division and other divisions worldwide, with all divisions having transparent, on-demand access to a range of documents.

Sources:

• PRNewswire, June 27, 1995
• Documentum Inc.
• Rank Xerox AG
• CIBA Ltd.